Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-01
DOI
10.1038/srep17288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-alcoholic fatty liver – Perhaps not so benign
- (2015) Leon A. Adams et al. JOURNAL OF HEPATOLOGY
- New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
- (2015) Ulrich Beuers et al. JOURNAL OF HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Starting the battle to control non-alcoholic steatohepatitis
- (2015) Vlad Ratziu LANCET
- Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis
- (2015) Jonathan G. Stine et al. LIVER TRANSPLANTATION
- Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
- (2015) Mohamed Asrih et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Comparative pharmacokinetic and pharmacodynamic response of single and double intraruminal doses of ivermectin and moxidectin in nematode-infected lambs
- (2015) M Lloberas et al. NEW ZEALAND VETERINARY JOURNAL
- LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver
- (2014) Woo-Cheol Sim et al. BIOCHEMICAL PHARMACOLOGY
- Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
- (2014) Christian Gege et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Failing FXR expression in the liver links aging to hepatic steatosis
- (2014) Philippe Lefebvre et al. JOURNAL OF HEPATOLOGY
- Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance
- (2014) Peter Arner et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice
- (2013) Yan Lu et al. GUT
- Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
- (2013) Giovanni Targher et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
- (2013) Xuelian Xiong et al. JOURNAL OF HEPATOLOGY
- Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2013) Yongjie Ma et al. PHARMACEUTICAL RESEARCH
- Ivermectin binding sites in human and invertebrate Cys-loop receptors
- (2012) Timothy Lynagh et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Moxidectin and the avermectins: Consanguinity but not identity
- (2012) Roger Prichard et al. International Journal for Parasitology-Drugs and Drug Resistance
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis
- (2011) Xuemei Ge et al. JOURNAL OF LIPID RESEARCH
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- Structural and functional insights into nuclear receptor signaling
- (2010) Lihua Jin et al. ADVANCED DRUG DELIVERY REVIEWS
- Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
- (2010) Zhao-Xia Yang et al. Hepatology International
- A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes
- (2010) Shuxin Han et al. MOLECULAR ENDOCRINOLOGY
- New ventures in the chemistry of avermectins
- (2009) Thomas Pitterna et al. BIOORGANIC & MEDICINAL CHEMISTRY
- FXR agonist activity of conformationally constrained analogs of GW 4064
- (2009) Adwoa Akwabi-Ameyaw et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B
- (2009) Yi-Cheng Chen et al. HEPATOLOGY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Exposure to the synthetic FXR agonist GW4064 causes alterations in gene expression and sublethal hepatotoxicity in eleutheroembryo medaka (Oryzias latipes)
- (2009) Deanna L. Howarth et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- FXR: a metabolic regulator and cell protector
- (2008) Yan-Dong Wang et al. CELL RESEARCH
- Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy
- (2008) Xiangbin Xing et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started